# The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

> **NCT07636200** · NA · RECRUITING · sponsor: **University of Colorado, Boulder** · enrollment: 250 (estimated)

## Conditions studied

- Advanced Solid Tumor Cancer
- Stage IV Cancer (Solid Tumors Only)
- Glioblastoma
- Stage III Ovarian Cancer
- Small Cell Lung Cancer Extensive Stage

## Interventions

- **BEHAVIORAL:** Written Exposure-Based Coping Intervention (EASE)
- **BEHAVIORAL:** Usual Care Control Condition

## Key facts

- **NCT ID:** NCT07636200
- **Lead sponsor:** University of Colorado, Boulder
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-04
- **Primary completion:** 2030-03
- **Final completion:** 2030-05
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-06-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07636200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07636200, "The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07636200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*